• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MHRA may allow drug reaction reporting through social media

MHRA may allow drug reaction reporting through social media

September 13, 2011
CenterWatch Staff

Drug reaction reporting from smartphones, Facebook and Twitter is being considered after the success of a scheme allowing direct reporting from GP practice IT systems, according to GP Online.

The MHRA is now “actively working on introducing other ways of reporting to make it easier and encourage more reporting.”

Mick Foy, group manager for vigilance and risk management of medicines at the MHRA, said, “Applications for smartphones, improved web reporting forms and the use of social media such as Twitter and Facebook are being carefully considered as potential routes for reporting.”

Valid reports have to contain information on the drug, reaction, patient and reporter, and allow the agency to follow-up reports, he continued.

“It is important to consider the structure of the information for inclusion on our database, something Twitter and Facebook do not easily lend themselves to,” said Foy.

Plans to expand submission of yellow cards follow the agency’s launch of direct reporting from practice IT systems in order to increase reports from GPs.

The 1,100 GP practices using the SystmOne IT system can use a yellow card reporting feature that interacts directly with the MHRA database.

Foy said the MHRA had now received 1,008 yellow cards direct from practice IT systems and expected to receive another 500 by the end of 2011.

“In 2010, a total of 2,237 yellow cards were received directly from GPs by all reporting methods,” he said. “An additional 1,500 yellow cards from SystmOne will mean more than a 60% annual increase.”

Foy said the MHRA was now in discussions with the government IT agency NHS Connecting for Health and individual GP IT system providers about introducing electronic yellow card reporting into other GP systems.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing